...
首页> 外文期刊>BMC Endocrine Disorders >Association between circulating microRNAs 486, 146b and 15b and serum betatrophin levels in obese; type 2 diabetic and non-diabetic children
【24h】

Association between circulating microRNAs 486, 146b and 15b and serum betatrophin levels in obese; type 2 diabetic and non-diabetic children

机译:循环微小RNA 486,146B和15B和肥胖的血清BERATROPHIN水平之间的关联; 2型糖尿病和非糖尿病儿童

获取原文
           

摘要

This study tested the association between serum levels of microRNA-486, ?146b and -15b and betatrophin in normal and obese children with/without type 2 diabetes mellitus (T2DM). the study included 120 children; divided into three groups: G1 (50 healthy), G2 (35 obese) and G3 (35 obese with T2DM). The levels of microRNA-486, 146b and 15b and serum betatrophin were measured by their corresponding methods. serum microRNA-486, ?146b, ?15b and betatrophin levels were significantly high in G3 followed by G2 then G1 (p?=?0.002, ?0.001, ?0.001, and??0.001, respectively). Especially in G3, these levels correlated positively with the BMI percentile (r?=?0.44, 0.58, 0.38, and 0.46, p?=?0.007, ?0.001, 0.021, and 0.005, respectively), serum glucose (r?=?0.56, 0.49, 0.82, 0.60, and 0.42, p??0.001, 0.003, ?0.001, and??0.001, respectively) and HbA1c% (r?=?0.56, 0.39, 0.66, and 0.42, p??0.001, 0.019, ?0.001, and 0.032, respectively) while, showed negative correlations with correlated with serum insulin levels (r?=???0.37, ??0.42, ??0.58, and???0.41, p?=?0.021, 0.012, ?0.001 and 0.013, respectively) and with serum C-peptide levels (r?=???0.76, ??0.50, ??0.35 and???0.42, p??0.001, 0.002, 0.036 and 0.011, respectively). Serum betatrophin levels correlated positively with microRNA-486, ?146b and -15b levels in G2 (r?=?0.35, 0.80, and 0.67, p?=?0.036, ?0.001, and,?0.001, respectively), and in G3 (r?=?0.57, 0.36, and 0.38, p??0.001, 0.029 and, 0.023, respectively). Circulating microRNA-486, 146b and 15b increase significantly in obese children with T2DM and these levels correlate positively with serum betatrophin levels. Further studies are required to test the role of targeting of these microRNAs and betatrophin in the timely management of obesity and/or T2DM in children.
机译:该研究测试了血清MicroRNA-486,α-146b和-15b和嗜酸性儿童的嗜睡素之间的关联和肥胖的儿童,肥胖儿童(T2DM)。该研究包括120名儿童;分为三组:G1(50健康),G2(35肥胖)和G3(35肥胖,T2DM)。通过其相应的方法测量MicroRNA-486,146B和15B和血清BERATROTROPHIN的水平。血清microRNA-486,α146b,α15b和betroTrophin水平在g3中显着高,然后g2均显着高,然后g1(p?= 0.002,>Δ0.001,> 0.001分别)。特别是在G3中,这些水平与BMI百分位系相关(R?= 0.44,0.58,0.38和0.46,P?= 0.007,> 0.001,0.021和0.005,分别),血清葡萄糖(R?= ?0.56,0.49,0.82,0.60和0.42,p?>〜0.001,2003,>?0.001,分别为1℃,2.001分别)和HBA1C%(R?= 0.56,0.39,0.66和0.42,P ?>?0.001,0.019,>?0.001和0.032,同时显示与血清胰岛素水平相关的负相关(R?= ??? 0.37,?? 0.42,?? 0.58,以及0.41, p?= 0.021,0.012,>α0.001和0.013,血清C-肽水平(R?= ??? 0.76,?? 0.50,?? 0.35和??? 0.42,p?>?0.001分别为0.002,0.036和0.011)。血清BERATROPHIN水平与MICRORNA-486带正相关,G2(R?= 0.35,0.80和0.67,P≤0.036,>Δ0.001,> <0.001)和,>?0.001分别)和,>?0.001分别分别的水平,α146b和-15b水平正相关。在g3(r?= 0.57,0.36和0.38,p?0.001,0.029和,0.023分别)。循环microRNA-486,146B和15B在具有T2DM的肥胖儿童中显着增加,并且这些水平随着血清BERATROPHIN水平呈正相关。需要进一步的研究来测试靶长和嗜睡蛋白的靶向的作用,并在儿童的及时管理肥胖症和/或T2DM。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号